Cite
HARVARD Citation
Tatovic, D. et al. (2022). Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Immunotherapy advances. 2 (1), p. . [Online].